Annual Report of Kerala Ayurveda Limited for FY 2025-26.

September 05, 2026 KAL/COR/BSE/09/ 1039/2026 The Manager Dept. of Corporate Services, Bombay Stock Exchange Ltd. Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001. Scrip Code-530163 Subject: Notice of 34th Annual General Meeting and Annual Report of Kerala Ayurveda Limited (‘the Company’) for the Financial Year 2025-26 Dear Sir / Madam, Pursuant to Regulation 30, 34, 36 and other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”), we wish to inform that the 34th Annual General Meeting (“AGM”) of the Company is scheduled to be held on Monday, September 28, 2026 at 11:00 am (IST) through Video Conference (“VC”)/ Other Audio Visual Means (“OAVM”) in compliance with the applicable provisions of the Companies Act, 2013 and the rules made thereunder read with General Circular No. 03/2025 dated September 22, 2025 issued by Ministry of Corporate Affairs, the SEBI Listing Regulations, and other applicable circulars issued in this regard by MCA and SEBI (collectively referred to as “Circulars”). The said Notice and Annual Report for the financial year 2025-26 are being sent through e-mails to the Members of the Company at their registered e-mail addresses and the same will also be available on the website of the stock exchange, BSE Limited (www.bseindia.com) and on the website of Central Depository Services (India) Limited (www.evotingindia.com). Further, in terms of Regulation 46 of the SEBI Listing Regulations, the said Annual Report and other relevant documents will also be available on the website of the Company at https://keralaayurveda.com/pages/investors. Additionally, pursuant to Regulation 36(1)(b) of SEBI Listing Regulations, the Company has also sent a letter to those shareholders whose email addresses are not registered with the Company / Registrar and Share Transfer Agent (“RTA”) / Depository Participants, providing them the web link, including the exact path for accessing the Company’s Annual Report and Notice of the 34th AGM. The Company has appointed Central Depository Services (India) Limited as the e-voting agency. Members holding shares in demat or physical form as on Monday, September 21, 2026 (“Cut-off Date”) will have the opportunity to cast their vote, on all resolutions as set out in the AGM Notice through: • Remote e-voting: from Friday, September 25, 2026 (9:00 A.M. IST) to Sunday, September 27, 2026 (5:00 P.M. IST) • E-voting during the AGM Registered Office: Corporate Office: Kerala Ayurveda Limited (An ISO 9001:2015 Certified Company) Kerala Ayurveda Limited (An ISO 9001:2015 Certified Company) XV/551, Athani, Nedumbassery, 12th Floor, Tower A, Summit @ Brigade Metropolis Ernakulam, Kerala, 683585. B-9, ITPL Main Road, CIN:L24233KL1992PLC006592 Garudacharpalya, Bengaluru, 560048 Ph: +91 484 2476301/2/3/4 Ph:+91- 080-43760897 email: info@keralaayurveda.biz www.keralaayurveda.biz The above announcement will also be made available on the website of the Company and can be accessed using the link i.e., https://keralaayurveda.com/pages/investors. Thanking You, For Kerala Ayurveda Limited Binu Thomas Company Secretary and Compliance Officer M No.: F11208 Encl.: as above Registered Office: Corporate Office: Kerala Ayurveda Limited (An ISO 9001:2015 Certified Company) Kerala Ayurveda Limited (An ISO 9001:2015 Certified Company) XV/551, Athani, Nedumbassery, 12th Floor, Tower A, Summit @ Brigade Metropolis Ernakulam, Kerala, 683585. B-9, ITPL Main Road, CIN:L24233KL1992PLC006592 Garudacharpalya, Bengaluru, 560048 Ph: +91 484 2476301/2/3/4 Ph:+91- 080-43760897 email: info@keralaayurveda.biz www.keralaayurveda.biz Table Of Contents Corporate information 4 Chairman’s Letter 5 Notice of AGM 12 Board’s Report and Annexures 40 Standalone Financials 170 Consolidated Financials 239 Page 3 CORPORATE INFORMATION BOARD OF DIRECTORS BOARD COMMITTEES AUDIT COMMITTEE Mr. Ramesh Vangal, Chairman Dr. Kunjupanicker Anilkumar, Whole Time Director Ms. Shilpa Kiran Gududur, Independent Director Mr. Rajesh Sharma, Independent Director Ms.ShilpaKiran Gududur, Chairman Mr. Kshiti Ranjan Das, Independent Director Mr.KshitiRanjan Das, Member Dr. Kodikannath Jayarajan, Non-Executive Director RajeshSharma, Member Mr. Utkarsh Singh, Non, Executive Director NOMINATION AND Mr.Saif Khan, Independent Director REMUNERATION COMMITTEE Mr. George K T Mr.Kshiti Ranjan Das.Chairman Mr. Ramesh Vangal. Member CEO Mr. Rajesh Sharma, Member Mr. Vivek Sunder STAKEHOLDERS RELATIONSHIP COMPANY SECRETARY COMMITTEE Mr. Binu Thomas Dr. Kodikannath Jayarajan, Chairman REGISTERED OFFICE & FACTORY Dr. Kunjupanicker Anilkumar, Member Mr. Rajesh Sharma, Member XV/551, Athani, Nedumbassery, Ernakulam, P.O, Aluva- 683 585, Kerala, India. REGISTRAR & TRANSFER AGENTS L24233KL1992PLC006592 M/s. Integrated Registry Management Services Pvt. Ltd. Kences Towers No.1 Ramakrishna CORPORATE OFFICE Street T Nagar, Chennai - 600 017. Kerala Ayurveda Limited, Summit-A, 12th Floor, Brigade Ph: 044-28140801-03, Fax : 044-28142479 E-mail : csdstd@integratedindia.in Summit, B-9, ITPL Main Rd, Brigade Metropolis, Garudachar Palya, Mahadevapura, Bengaluru, Karnataka STATUTORY AUDITORS 560048, India SECRETARIAL AUDITORS G. Joseph & Associates, Chartered Accountants 37/2038, First Floor, Muttathil Lane M/s. SVJS & Associates, Company Secretaries 39/3519 Kadavanthara, Cochin 682020 B,1st Floor Padmam Apartments, Manikkath Road, Ravipuram, Kochi – 682017. INTERNAL AUDITORS BANKERS Mr. Alphonse Scaria, SBM Bank (India) Ltd 1st Floor, Mundackal, Samthripthy Lane Cheruparambathu Road, Kadavanthra P.O Kochi – 682020, Kerala Page 4 Page 5 CHAIRMAN’S LETTER Dear Shareholders, The rationale behind these investments has been The financial year 2025–26 was an important chapter in straightforward: to build the capabilities today that the continuing transformation of Kerala Ayurveda can support significantly larger businesses Limited. It was a year in which the investments we have tomorrow. made in people, technology, brands, infrastructure and new business platforms began translating into stronger FY 2025–26 provided encouraging evidence that these capabilities are beginning to gain traction. business momentum. Our consolidated revenue for FY 2025–26 stood at Growth Across Our Key ₹145.4 crore, representing 19% growth over the previous Businesses year and 22% growth excluding the impact of the discontinued Nutraveda business. More significantly, our Our Global E-Product business grew 37% during standalone business crossed the ₹100 crore revenue the year. The most significant development was the milestone for the first time, reflecting the growing acceleration of our India D2C business, which strength of our India operations. delivered growth of more than 270%, accompanied by approximately six-fold growth in unit volumes. These are encouraging milestones. However, we also Our US e-commerce business also delivered strong recognize that revenue growth alone does not define growth, supported by improved product listings, success. As a listed company, our responsibility is regional stock availability and focused marketing ultimately to build a business that delivers sustainable investments. growth, improving profitability, healthy cash generation and enduring value for our shareholders. Our Global Health Services business grew 29%, supported by improved resort performance, the That remains the central focus of the next phase of our addition of the Singapore business and the phased journey. implementation of our Clinics Growth Model. Five new clinics were opened during the year, while Building a Stronger KAL Ayurvedagram achieved occupancy levels above Our long-term strategy continues to be anchored in 85%. Vision 2030, under which we aspire to build a ₹1,000 crore enterprise by 2030. Our focus is increasingly Our US Academy and Wellness Center business concentrated on businesses where we see the greatest g [Showing first 8,000 characters — download PDF for full document]